Which mRNA vaccines are approved or under development in Switzerland?
The mRNA vaccines developed by Moderna (Spikevax®) and Pfizer/Biontech (Comirnaty®) are available in Switzerland.
In addition to the original vaccines, three booster vaccines specifically targeting the Omicron variant are also authorized:
specifically against the Omicron XBB.1.5 subvariant the vaccines Spikevax® Omicron XBB.1.5 et Comirnaty® XBB.1.5
specifically against the Omicron BA.4/5 subvariants the vaccines Spikevax® Original / Omicron BA.4-5 (mRNA-1273.222) and Comirnaty® Bivalent Original/ Omicron BA.4-5 (Tozinameran / Famtozinameran)
- specifically against the Omicron BA.1 subvariant the vaccines Spikevax® Bivalent Original / Omicron (mRNA-1273.214) and Comirnaty® Bivalent Original / Omicron BA.1 (Tozinameran / Riltozinameran)
- What is an mRNA and what is its function?
- How do mRNA vaccines work?
- Which mRNA vaccines are approved or under development in Switzerland?
- Does the mRNA vaccine affect our genetic material?
- What do the approved mRNA vaccines contain?
- What side effects are known and expected for the approved mRNA vaccines?
- How effective are the approved mRNA vaccines?
- How and why are mRNAs modified for the vaccines?
- Is the technology behind the mRNA vaccines new?
- Why were mRNA vaccines earlier available than conventional vaccines?